$157.12
Value $117B
BKNG and DORM stock compared: price, dividend, valuation and results, from SEC filings.
$157.12
Value $117B
$131.29
Value $4.0B
Booking (BKNG) has a market value of $117B and Dorman Products (DORM) $4.0B. Over the last year, with dividends, BKNG moved -21.5% and DORM -0.3%. The P/E is 16.3 for BKNG and 19.6 for DORM. Dividend yield: BKNG 1.05%, DORM none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
BKNG$117B
DORM$4.0B
BKNG is 29 times DORM
Revenue, 12 months
BKNG$28.1B
DORM$2.2B
BKNG is 13 times DORM
Net income, 12 months
BKNG$7.2B
DORM$202M
BKNG is 36 times DORM
Operating margin
BKNG32.8%
DORM13.3%
19.5 points apart
ROIC
BKNG66.1%
DORM11.0%
55.1 points apart
P/E
BKNG16.3
DORM19.6
DORM is 1.2 times BKNG
Dividend yield
BKNG1.1%
DORM0.0%
1.1 points apart
5-year return
BKNG+67.2%
DORM+11.6%
55.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
BKNG+67.2%
DORM+11.6%
| Period | BKNGWith dividends | DORMWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -21.5%Price -22.2% | -0.3%Price -0.3% |
| 3 years since November 16, 2023 | +28.5%+8.7% a yearPrice +25.5% | +87.0%+23.2% a yearPrice +87.0% |
| 5 years since November 15, 2021 | +67.2%+10.8% a yearPrice +63.3% | +11.6%+2.2% a yearPrice +11.6% |
| 10 years since November 16, 2016 | +167.5%+10.3% a yearPrice +161.3% | +89.3%+6.6% a yearPrice +89.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
BKNGBookingDORMDorman Products
| Price | $157.12 | $131.29 |
|---|---|---|
| Market value | $117B | $4.0B |
| Enterprise value (EV) | $121B | $4.2B |
| P/E | 16.3 | 19.6 |
| P/E, 5-year median | – | 21.0 |
| P/B | – | 2.5 |
| EV/EBIT | 13.1 | 14.7 |
| Free cash flow yield | 7.9% | 6.8% |
| Revenue, 12 months | $28.1B | $2.2B |
|---|---|---|
| Net income, 12 months | $7.2B | $202M |
| Free cash flow, 12 months | $9.2B | $269M |
| Earnings per share, 12 months | $9.26 | $6.72 |
| Revenue growth, year on year | 13.4% | 6.0% |
| Revenue growth a year, past | +31.7%over 5 years | +14.3%over 5 years |
| EPS growth a year, past | +158.3%over 5 years | +15.0%over 5 years |
| Gross margin | – | 41.1% |
|---|---|---|
| Operating margin | 32.8% | 13.3% |
| Net margin | 25.5% | 9.3% |
| ROIC | 66.1% | 11.0% |
| ROE | – | 13.5% |
| Cash | $15.8B | $167M |
|---|---|---|
| Total debt | $20.6B | $523M |
| Net debt / EBITDA | 0.4 | 0.8 |
| Interest cover | 8.3× | 10.7× |
| Dividend yield | 1.1% | – |
|---|---|---|
| Dividend per share, 12 months | $1.64 | – |
| Dividend growth a year, past | – | – |
| Buyback yield | 5.5% | – |
| Shareholder yield | 6.6% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Booking ($117B) is about 29.5 times Dorman Products ($4.0B), at today's prices.
Since November 16, 2016, BKNG's price moved +161.3% and DORM's +89.3%. With dividends: BKNG +167.5% (+10.3% a year), DORM +89.3% (+6.6% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.05% for Booking and none for Dorman Products. Over the last twelve months they paid $1.64 and – per share.
At today's price, the P/E is 16.3 for BKNG and 19.6 for DORM. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 25.5% for Booking and 9.3% for Dorman Products, and the operating margin 32.8% and 13.3%. Revenue was $28.1B and $2.2B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.